Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.

Lohr JG, Kim S, Gould J, Knoechel B, Drier Y, Cotton MJ, Gray D, Birrer N, Wong B, Ha G, Zhang CZ, Guo G, Meyerson M, Yee AJ, Boehm JS, Raje N, Golub TR.

Sci Transl Med. 2016 Nov 2;8(363):363ra147.

2.

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.

Yee AJ, Bensinger WI, Supko JG, Voorhees PM, Berdeja JG, Richardson PG, Libby EN, Wallace EE, Birrer NE, Burke JN, Tamang DL, Yang M, Jones SS, Wheeler CA, Markelewicz RJ, Raje NS.

Lancet Oncol. 2016 Nov;17(11):1569-1578. doi: 10.1016/S1470-2045(16)30375-8. Epub 2016 Sep 17.

PMID:
27646843
3.

Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Nipp RD, Lee H, Powell E, Birrer NE, Poles E, Finkelstein D, Winkfield K, Percac-Lima S, Chabner B, Moy B.

Oncologist. 2016 Apr;21(4):467-74. doi: 10.1634/theoncologist.2015-0481. Epub 2016 Mar 14.

4.

Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature.

Birrer N, Chinchilla C, Del Carmen M, Dizon DS.

Am J Clin Oncol. 2018 Mar;41(3):313-315. doi: 10.1097/COC.0000000000000269.

PMID:
26840041
5.

Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma.

O'Donnell E, Mahindra A, Yee AJ, Nardi V, Birrer N, Horick N, Borger D, Finkelstein D, Iafrate JA, Raje N.

EBioMedicine. 2014 Nov 18;2(1):71-3. doi: 10.1016/j.ebiom.2014.11.008. eCollection 2015 Jan.

6.

Effect of Educational Intervention on Cervical Cancer Prevention and Screening in Hispanic Women.

Foley OW, Birrer N, Rauh-Hain JA, Clark RM, DiTavi E, Del Carmen MG.

J Community Health. 2015 Dec;40(6):1178-84. doi: 10.1007/s10900-015-0045-x.

PMID:
26026277

Supplemental Content

Loading ...
Support Center